Danaher to acquire Masimo for $180/share cash; total value $9.9B

MASIMO CORP

Masimo shareholders to receive $180.00 per share in cash for each share held.
Total enterprise value of $9.9 billion; transaction unanimously approved by both boards.
Masimo to operate as a standalone business unit within Danaher's Diagnostics segment.
Politan Capital Management, holding significant Masimo shares, agreed to vote in favor.
Closing expected in H2 2026, subject to regulatory approvals and shareholder vote.

item 1.01item 7.01item 5.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.